Gainers

• Tenon Medical (NASDAQ:TNON) stock moved upwards by 48.8% to $3.63 during Thursday's pre-market session. The market value of their outstanding shares is at $1.6 million.
• AEON Biopharma (AMEX:AEON) stock moved upwards by 38.83% to $0.32. The market value of their outstanding shares is at $11.5 million.
• Silexion Therapeutics (NASDAQ:SLXN) shares moved upwards by 13.19% to $0.4. The market value of their outstanding shares is at $1.9 million.
• Oncolytics Biotech (NASDAQ:ONCY) shares moved upwards by 12.16% to $0.89. The company's market cap stands at $101.3 million.
• Nomad Power Solutions (NASDAQ:NMAD) shares rose 7.81% to $4.0. The company's market cap stands at $67.8 million.
• Imunon (NASDAQ:IMNN) stock moved upwards by 7.28% to $1.62. The market value of their outstanding shares is at $8.4 million.

Losers

• Cooper Companies (NASDAQ:COO) shares decreased by 18.5% to $51.72 during Thursday's pre-market session. The market value of their outstanding shares is at $12.3 billion. The company's, Q3 earnings came out yesterday.
• Radiopharm Theranostics (NASDAQ:RADX) stock decreased by 18.27% to $1.7. The company's market cap stands at $30.0 million.
• CDT Equity (NASDAQ:CDT) stock declined by 17.7% to $0.49. The company's market cap stands at $8.2 million.
• Biohaven (NYSE:BHVN) stock decreased by 13.27% to $13.01. The company's market cap stands at $2.2 billion.
• BioLine Rx (NASDAQ:BLRX) shares declined by 12.95% to $2.22. The company's market cap stands at $12.3 million.
• Biomerica (NASDAQ:BMRA) stock fell 10.78% to $2.02. The market value of their outstanding shares is at $10.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.